LAG3 is upregulated in breast cancer tissues, especially enriched in HER2-positive patients and those with high tumor grade, indicating that high expression of LAG3 is indicative of highly malignant breast cancer (Shi et al. 2022). Here, ERBB2 is linked to breast carcinoma.